Elisabeth Hildt

1.8k total citations
48 papers, 760 citations indexed

About

Elisabeth Hildt is a scholar working on Cognitive Neuroscience, Safety Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Elisabeth Hildt has authored 48 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cognitive Neuroscience, 10 papers in Safety Research and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Elisabeth Hildt's work include Neuroethics, Human Enhancement, Biomedical Innovations (18 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Ethics and Social Impacts of AI (5 papers). Elisabeth Hildt is often cited by papers focused on Neuroethics, Human Enhancement, Biomedical Innovations (18 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Ethics and Social Impacts of AI (5 papers). Elisabeth Hildt collaborates with scholars based in United States, Germany and Switzerland. Elisabeth Hildt's co-authors include Andreas G. Franke, Klaus Lieb, Andreas Fellgiebel, Clément Levallois, Martin Rohm, Abdul Al-Khodairy, Iolanda Pisotta, Robert Leeb, Christiana Bagusat and Angela Riccio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Psychology.

In The Last Decade

Elisabeth Hildt

46 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Hildt United States 16 515 171 101 82 62 48 760
Jonathan Leo United States 11 216 0.4× 298 1.7× 47 0.5× 84 1.0× 150 2.4× 38 848
Jolanta Masiak Poland 13 236 0.5× 92 0.5× 105 1.0× 59 0.7× 95 1.5× 76 649
George King United States 14 232 0.5× 66 0.4× 245 2.4× 86 1.0× 68 1.1× 34 768
Marios Adamou United Kingdom 16 427 0.8× 654 3.8× 33 0.3× 25 0.3× 218 3.5× 55 957
Trudi Edginton United Kingdom 16 174 0.3× 116 0.7× 57 0.6× 58 0.7× 201 3.2× 37 925
Zhiling Zou China 12 253 0.5× 63 0.4× 86 0.9× 30 0.4× 141 2.3× 23 631
Jun Won Kim South Korea 16 269 0.5× 141 0.8× 42 0.4× 20 0.2× 192 3.1× 61 788
Eran Klein United States 18 487 0.9× 90 0.5× 275 2.7× 12 0.1× 73 1.2× 67 944
John A. Hansen United States 7 448 0.9× 152 0.9× 32 0.3× 15 0.2× 160 2.6× 12 984
David Benrimoh Canada 13 288 0.6× 148 0.9× 13 0.1× 97 1.2× 60 1.0× 45 632

Countries citing papers authored by Elisabeth Hildt

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Hildt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Hildt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Hildt more than expected).

Fields of papers citing papers by Elisabeth Hildt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Hildt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Hildt. The network helps show where Elisabeth Hildt may publish in the future.

Co-authorship network of co-authors of Elisabeth Hildt

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Hildt. A scholar is included among the top collaborators of Elisabeth Hildt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Hildt. Elisabeth Hildt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hildt, Elisabeth. (2025). What Is the Role of Explainability in Medical Artificial Intelligence? A Case-Based Approach. Bioengineering. 12(4). 375–375. 13 indexed citations
2.
Amann, Julia, Megan Coffee, Boris Düdder, et al.. (2023). Lessons Learned from Assessing Trustworthy AI in Practice. Theseus (Ammattikorkeakoulujen). 2(3). 13 indexed citations
3.
Hildt, Elisabeth, et al.. (2023). Ethics and Transparency Issues in Digital Platforms: An Overview. SHILAP Revista de lepidopterología. 4(4). 831–844. 6 indexed citations
4.
Hildt, Elisabeth, et al.. (2022). Investigating user perceptions of commercial virtual assistants: A qualitative study. Frontiers in Psychology. 13. 944714–944714. 1 indexed citations
5.
Hildt, Elisabeth. (2021). Affective Brain-Computer Music Interfaces—Drivers and Implications. Frontiers in Human Neuroscience. 15. 711407–711407. 4 indexed citations
6.
Laas, Kelly, et al.. (2020). Infusing Ethics in Research Groups: A Bottom-Up, Context-Specific Approach.. AEE Journal. 3 indexed citations
7.
Hildt, Elisabeth. (2019). Multi-Person Brain-To-Brain Interfaces: Ethical Issues. Frontiers in Neuroscience. 13. 1177–1177. 16 indexed citations
8.
Hildt, Elisabeth. (2019). Artificial Intelligence: Does Consciousness Matter?. Frontiers in Psychology. 10. 1535–1535. 46 indexed citations
9.
Pohl, Sabine, et al.. (2018). Moral Attitudes Toward Pharmacological Cognitive Enhancement (PCE): Differences and Similarities Among Germans With and Without PCE Experience. Frontiers in Pharmacology. 9. 1451–1451. 6 indexed citations
10.
Levallois, Clément, et al.. (2016). Neuroethics 1995–2012. A Bibliometric Analysis of the Guiding Themes of an Emerging Research Field. Frontiers in Human Neuroscience. 10. 336–336. 44 indexed citations
11.
Hildt, Elisabeth, Klaus Lieb, Christiana Bagusat, & Andreas G. Franke. (2015). Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study. BioMed Research International. 2015. 1–7. 22 indexed citations
12.
Hildt, Elisabeth, et al.. (2014). Life context of pharmacological academic performance enhancement among university students – a qualitative approach. BMC Medical Ethics. 15(1). 23–23. 48 indexed citations
13.
Hildt, Elisabeth & Andreas G. Franke. (2013). Cognitive enhancement : an interdisciplinary perspective. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 28 indexed citations
14.
Franke, Andreas G., Klaus Lieb, & Elisabeth Hildt. (2012). What Users Think about the Differences between Caffeine and Illicit/Prescription Stimulants for Cognitive Enhancement. PLoS ONE. 7(6). e40047–e40047. 57 indexed citations
15.
Franke, Andreas G., et al.. (2012). Charakteristika von Studierenden, die pharmakologisches Neuroenhancement mit Stimulanzien betreiben: Eine Pilotstudie. Psychiatrische Praxis. 39(4). 174–180. 15 indexed citations
17.
Franke, Andreas G., et al.. (2010). Non-Medical Use of Prescription Stimulants and Illicit Use of Stimulants for Cognitive Enhancement in Pupils and Students in Germany. Pharmacopsychiatry. 44(2). 60–66. 167 indexed citations
18.
Hildt, Elisabeth. (2008). Living longer: age retardation and autonomy. Medicine Health Care and Philosophy. 12(2). 179–185. 1 indexed citations
19.
Hildt, Elisabeth. (2008). Autonomie in der Medizin. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 51(8). 827–834. 1 indexed citations
20.
Hildt, Elisabeth. (1996). Hirngewebetransplantation und personale Identität. Duncker & Humblot eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026